Overview

A 410-gene solid tumor panel supports broad comprehensive genomic profiling across many cancer types in a single test. For distributors, hospitals, and reference laboratories, the value of such a panel depends not only on the gene list but also on reliable sourcing, sample logistics, and consistent turnaround. This article focuses on the procurement and supply dimensions that determine whether a high-throughput panel performs dependably in routine B2B workflows.

Choosing a Panel Format

Broad solid tumor panels are offered as hybridization-capture or amplicon-based kits, and sometimes as lab-developed services. Capture-based designs typically cover more genes and intronic regions important for fusion detection, while amplicon designs suit low-input or degraded FFPE samples. Buyers should match the format to their dominant sample types and to the instrumentation already installed, because platform compatibility drives both cost and adoption.

Sample and Cold-Chain Logistics

Most panels accept FFPE sections, frozen tissue, or cfDNA, but each demands different handling. FFPE blocks or unstained slides should be shipped with a cold pack, ensuring the pack never touches the specimen directly, and accompanied by fixative and storage documentation. Plasma for ctDNA must be separated and stabilized promptly. Clear chain-of-custody and temperature logging reduce pre-analytical loss that no assay can recover later.

Service Level and Minimum Order

Commercial arrangements vary by volume. Some suppliers set a minimum order quantity to keep per-sample reagent cost viable, while others price per reported sample. Turnaround time typically ranges from roughly one to three weeks depending on batching and validation workload. Procurement teams should confirm whether reporting, bioinformatics support, and re-run policies are included, since these terms materially affect total cost of ownership.

Beyond transport, buyers should plan for the documentation and regulatory paperwork that accompanies cross-border diagnostic shipments. A commercial invoice, certificate of analysis, and clear sample provenance reduce the risk of customs delays that could compromise sample integrity. Establishing a standing agreement with a logistics partner familiar with clinical specimens also smooths recurring orders and helps maintain the consistent conditions that broad panels require for reproducible results.

FAQ

Q: What sample types can a 410-gene panel accept? A: Most broad panels accept FFPE tissue, frozen tissue, and cfDNA, though each requires specific collection and transport conditions.

Q: How should FFPE samples be shipped? A: Ship sections or blocks with an insulated cold pack that does not contact the specimen directly, plus fixation and storage records.

Q: Is a minimum order quantity typical? A: Many suppliers apply a minimum order to keep reagent costs reasonable; exact thresholds depend on the vendor and service model.

Q: What does turnaround usually include? A: Turnaround covers sequencing, bioinformatics, and reporting, but buyers should confirm whether validation and re-runs are included in the quoted window.